The Scientific World Journal / 2013 / Article / Tab 2

Research Article

The Prevalence and Awareness of Cardiometabolic Risk Factors in Southern Chinese Population with Coronary Artery Disease

Table 2

Patients demographic stratified by disease status.

VariableMaleFemaleTotal value
ACS
( )
Others
( )
valueACS
( )
Others
( )
valueACS
( )
Others
( )

Age (years)61.2 ± 0.463.3 ± 0.50.00167.1 ± 0.567.1 ± 0.50.94163.1 ± 0.364.5 ± 0.40.004
Body mass index (kg/m2)23.8 ± 0.124.2 ± 0.10.02623.8 ± 0.224.1 ± 0.20.23223.8 ± 0.124.1 ± 0.10.014
Systolic blood pressure (mmHg)130 ± 1132 ± 10.021134 ± 1136 ± 10.325131 ± 1133 ± 10.017
Diastolic blood pressure (mmHg)76 ± 177 ± 10.05176 ± 176 ± 10.55876 ± 177 ± 10.052
Total cholesterol (mmol/L)4.52 ± 0.044.45 ± 0.050.3064.94 ± 0.064.87 ± 0.060.4284.66 ± 0.034.59 ± 0.040.168
Low-density lipoprotein cholesterol (mmol/L)2.89 ± 0.042.77 ± 0.060.0973.06 ± 0.052.99 ± 0.050.3372.95 ± 0.032.84 ± 0.040.050
High-density lipoprotein cholesterol (mmol/L)0.99 ± 0.011.06 ± 0.01<0.0011.15 ± 0.021.18 ± 0.020.2231.04 ± 0.011.10 ± 0.01<0.001
Triglycerides (mmol/L)1.82 ± 0.041.74 ± 0.060.3101.83 ± 0.061.86 ± 0.060.7281.83 ± 0.041.78 ± 0.050.432
Lysophosphatidic acid (g/L)0.39
(0.23, 0.88)
0.34
(0.21, 0.65)
0.0050.39
(0.22, 0.86)
0.33
(0.20, 0.58)
0.0230.39
(0.23, 0.87)
0.34
(0.21, 0.61)
<0.001
Apolipoprotein A (g/L)1.02 ± 0.011.11 ± 0.01<0.0011.17 ± 0.011.24 ± 0.02<0.0011.07 ± 0.011.15 ± 0.01<0.001
Apolipoprotein B (g/L)0.78 ± 0.010.73 ± 0.01<0.0010.85 ± 0.020.79 ± 0.020.0180.81 ± 0.010.75 ± 0.01<0.001
Fasting glucose (mmol/L)6.45 ± 0.085.97 ± 0.11<0.0017.07 ± 0.166.09 ± 0.16<0.0016.64 ± 0.075.98 ± 0.09<0.001
Uric acid (umol/L)385±4404 ± 50.002342 ± 6358 ± 60.041371 ± 3388 ± 4<0.001
Duration of coronary artery disease (years)
 First diagnosed patients ( )
 History diagnosed patients ( )2.00
(0.77, 6.31)
2.42
(1.00, 6.99)
0.0313.21
(0.94, 9.78)
5.07
(2.00, 10.5)
0.0022.43
(0.79, 7.15)
3.67
(1.17, 8.96)
<0.001
Marriage (%)94.592.70.32979.583.70.31690.589.10.454
Years of education (%)0.5950.2070.271
 ≤957.956.472.366.862.160.5
 10–1220.723.116.517.019.520.7
 ≥1321.420.511.216.218.418.8
Physical activities (%)0.0300.4450.066
 None41.731.929.833.238.332.4
 ≤30 min18.223.422.622.619.523.1
 >30 min40.144.747.644.242.244.5
Smoking (%)<0.001<0.001<0.001
 Never37.548.394.796.153.467.6
 Past8.914.71.62.56.99.8
 Current53.637.03.71.439.722.7
Alcohol drinking (%)0.0940.0210.006
 Never68.765.798.697.777.478.6
 Past9.511.40.00.86.87.1
 Current21.822.81.41.515.814.3
Coronary artery stenosis degree of CAG<0.001<0.001<0.001
 Not conduct19.643.439.958.525.249.5
 <50%6.518.47.722.56.920.1
 50–74.9%7.39.38.57.27.68.4
 ≥75%66.628.943.911.860.322.0
Triple vessel disease (%) ( with coronary angiography)58.639.0<0.00154.825.4<0.00157.834.8<0.001
Treatment of coronary disease (%)
 Percutaneous coronary intervention71.937.9<0.00153.615.2<0.00166.528.1<0.001
 Coronary artery bypass graft2.63.30.4701.50.90.4642.32.30.972
 Hypertension49.359.10.00164.063.80.95653.661.10.001
 Diabetes mellitus26.823.70.18138.528.50.00330.125.60.021
 Dyslipidemia23.923.70.91826.029.30.30524.526.00.423
Current prevalence of diseases (%)
 Hypertension
 (≥140/90 mmHg for SBP/DBP or drug use)
92.888.90.01592.989.00.07592.989.00.002
 Diabetes mellitus
 (≥7.0 mmol/L for FPG or drug use)
42.135.10.01449.337.10.00144.236.0<0.001
 Dyslipidemia*95.889.9<0.00191.286.60.05794.488.5<0.001
Awareness rate of disease (%)
 Hypertension56.967.5<0.00170.772.80.54260.969.7<0.001
 Diabetes mellitus60.868.90.06071.671.60.99364.270.10.071
 Dyslipidemia25.229.30.10229.635.90.09026.431.90.007
The metabolic syndrome and its individual components (%)
 Metabolic syndrome (BMI ≥25 kg/m2)56.550.00.01665.864.20.64059.155.90.129
 Metabolic syndrome
 (BMI ≥25 kg/m2, with waist  circumference)
56.351.90.22766.867.60.88058.958.00.776
 Metabolic syndrome
 (waist circumference, )
62.758.20.21181.379.10.60267.266.40.770
 Obesity (BMI ≥25 kg/m2)33.236.80.15432.934.10.71933.135.70.196
 Obesity
 (waist circumference >85/80 cm for male/female)
52.256.70.19182.184.20.58559.467.10.005
 Triglycerides (≥1.70 mmol/L)39.831.30.00143.341.70.64540.835.50.012
 High-density lipoprotein cholesterol
 (<1.0/1.3 mmol/L for male/female)
53.843.4<0.00169.069.20.95558.054.00.060
 High blood pressure
 (≥130/85 mmHg for SBP/DBP)
94.592.30.11894.093.20.64594.492.70.128
 Fasting plasma glucose (≥5.6 mmol/L)59.251.70.00566.854.60.00161.352.9<0.001

Only 1303 but not all study samples measured waist circumference. CAG: coronary angiography.
*Dyslipidemia was defined as any one of triglyceride ≥2.26 mmol/L, total cholesterol ≥6.22 mmol/L, low-density lipoprotein cholesterol ≥4.14 mmol/L, and high-density lipoprotein cholesterol <1.04 mmol/L and/or using cholesterol-lowering medicines during the last 2 weeks.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.